TickerFactsScreenerDevelopers

NovoCure Ltd (NVCR) — Cost of Revenue

Annual figures by fiscal year, from SEC filings.

2013: $7.01M2014: $10.04M2015: $20.61M2016: $39.87M2017: $55.61M2018: $80.05M2019: $88.61M2020: $106.50M2021: $114.88M2022: $114.87M2023: $128.28M2024: $137.18M2025: $166.88M$166.88M
2013Cost of Revenue (USD)2025
Fiscal YearCost of RevenueChange YoY
2025$166.88M+21.6%
2024$137.18M+6.9%
2023$128.28M+11.7%
2022$114.87M-0.0%
2021$114.88M+7.9%
2020$106.50M+20.2%
2019$88.61M+10.7%
2018$80.05M+43.9%
2017$55.61M+39.5%
2016$39.87M+93.4%
2015$20.61M+105.4%
2014$10.04M+43.1%
2013$7.01M—